Sign inJoin waitlistJoin the waitlist

OJ

Olivia de Jong

Office of the Clinical Director · Clinical Center at the National Institutes of Health

Credentials: · · ·

History

Clinical Director · Clinical Center at the National Institutes of Health
Present

Research

A phase 2 trial of burosumab for treatment of fibroblast growth factor-23-mediated hypophosphatemia in children and adults with fibrous dysplasia
Bone Research · 2026 · First of 10 authors